Clinical Trial

Menstrual Cycle and Exercise-induced Muscle Damage

Study acronym: MC-EIMD
Completed
View on ClinicalTrials.gov →
Summary
The aim of the study is to investigate the effect of the different menstrual cycle phases on the recovery from exercise-induced muscle injury in eumenorrheic women. For this purpose, in a cross-over, randomized study, at least 10 healthy eumenorrheic women aged 18-35 years will participate. In a random order, the participants will perform 45 min downhill (-15% slope) running on a treadmill at 70% HRmax followed by a maximal time-trial (95% HRmax) to exhaustion: i) during the follicular phase and ii) during the luteal phase. Before the exercise protocol, as well as at 24 h, 48 h and 72 h following exercise, complete blood count, delayed onset of muscle soreness (DOMS), creatine kinase activity, countermovement jump, isometric, concentric and eccentric strength of knee extensors and knee flexors, will be assessed. In addition, lactic acid concentration will be assessed before and immediately following exercise, and DOMS will be assessed immediately after the end of exercise. Following a washout period of ≥28 days (depending on the length of the menstrual cycle), participants will repeat the exact same procedure for the remaining phase of the menstrual cycle.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-12-29.
Status change: Active, Not Recruiting → Completed 2026-02-01
Trial Details
NCT Number NCT07322874
Lead Sponsor Chariklia K. Deli
Conditions Menstrual Cycle Phase
Enrollment 15 participants
Start Date 2025-03-01
Primary Completion 2025-12-30 (estimated)
Study Completion 2025-12-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-03